TBCRC 008: Early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer
Roisin M. Connolly, Jeffrey P. Leal, Matthew P. Goetz, Zhe Zhang, Xian C. Zhou, Lisa K. Jacobs, Joyce Mhlanga, H. O. Joo, John Carpenter, Anna Maria Storniolo, Stanley Watkins, John H. Fetting, Robert S. Miller, Kostandinos Sideras, Stacie C. Jeter, Bridget Walsh, Penny Powers, Jane Zorzi, Judy C. Boughey, Nancy E. DavidsonLisa A. Carey, Antonio C. Wolff, Nagi Khouri, Edward Gabrielson, Richard L. Wahl, Vered Stearns
Dive into the research topics of 'TBCRC 008: Early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer'. Together they form a unique fingerprint.